Global Drug Discovery Services Market – Industry Analysis and Forecast (2017-2024) _ by Process, by Type, by Drug Type, by Therapeutic Area, and by Geography

Global Drug Discovery Services Market – Industry Analysis and Forecast (2017-2024) _ by Process, by Type, by Drug Type, by Therapeutic Area, and by Geography

Market Scenario

Global Drug Discovery Services Market is expected to reach USD 18.15 Billion by 2024 from USD 7.52 Billion in 2016 at CAGR of 11.64%. Increasing research & development expenditure, increasing patient pool, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, government assistance, rising funding & reimbursement, increasing demand for outsourcing of analytical testing and clinical trial services, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, growing awareness about chronic diseases, is driving the drug discovery services market.   Global Drug Discovery Service Market   Process segment of drug discovery services is segmented into target selection, target validation, and hit-to-lead identification. Hit-To-Lead identification is anticipated to lead maximum share. Research based on the high-throughput screening (HTS) is the main factor driving the use of hit-to-lead identification process Medicinal chemistry, biology services, and drug metabolism and pharmacokinetics. Medicinal chemistry segment is expected to dominate the market during the forecast period, owing to increasing number of drug discovery and developmental activities, and increasing inclination of pharmaceutical companies towards outsourcing. Drug type segment is bifurcated as small molecules and biologics. Small molecules are more preferred than biologics. Small molecules are easy to characterize, simple and well defined. Small molecules can easily enter cells, and can cause cancer cells to die hence is leading drug discovery services market. Geographically, North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. North America is expected to dominate the drug discovery services market in the forecast period followed by Europe and the Asia Pacific. Technologically advanced research platforms existence and early adoption of highly developed technologies and a supportive economic structure will fuel the drug discovery services market in the North America region. Scope of the Report: Drug Discovery Services Market, By Process: • Target Selection • Target Validation • Hit-To-Lead Identification • Lead Optimization • Candidate Validation Drug Discovery Services Market, By Therapeutic Area: • Oncology • Neurology • Cardiovascular Diseases • Respiratory Disorders • Diabetes • Other Therapeutic Areas Drug Discovery Services Market, By Drug Type: • Small Molecules • Biologics Drug Discovery Services Market, By Type: • Medicinal Chemistry • Biology Services • Drug Metabolism and Pharmacokinetics (DMPK) Drug Discovery Services Market, By Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America Key Players in the Drug Discovery Services Market: • GE Healthcare • Albany Molecular Research, Inc. (AMRI) • Pharmaceutical Product Development, LLC. (Ppd) • Syngene • Wuxi Apptec • Galapagos NV • Aurigene Discovery Technologies • Genscript Biotech Corporation • WIL Research Laboratories LLC • Covance • Jubilant Biosys • Evotec • Charles River Laboratories International • Merck • Thermo Fisher Scientific Global Oncology Information System Market : Global Industry Analysis and Forecast 2024

Table of Contents

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GLOBAL DRUG DISCOVERY SERVICES MARKET, BY PROCESS (2017-2024) 5.1. Introduction 5.2. Target Selection 5.2.1. Target Selection Market Overview 5.2.2. Target Selection Market Size & Forecast 5.3. Target Validation 5.3.1. Target Validation Market Overview 5.3.2. Target Validation Market Size & Forecast 5.4. Hit-To-Lead Identification 5.4.1. Hit-To-Lead Identification Market Overview 5.4.2. Hit-To-Lead Identification Market Size & Forecast 5.5. Lead Optimization 5.5.1. Lead Optimization Market Overview 5.5.2. Lead Optimization Market Size & Forecast 5.6. Candidate Validation 5.6.1. Candidate Validation Market Overview 5.6.2. Candidate Validation Market Size & Forecast 6. GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA (2017-2024) 6.1. Introduction 6.2. Oncology 6.2.1. Oncology Market Overview 6.2.2. Oncology Market Size & Forecast 6.3. Neurology 6.3.1. Neurology Market Overview 6.3.2. Neurology Market Size & Forecast 6.4. Cardiovascular Diseases 6.4.1. Cardiovascular Diseases Market Overview 6.4.2. Cardiovascular Diseases Market Size & Forecast 6.5. Respiratory Disorders 6.5.1. Respiratory Disorders Market Overview 6.5.2. Respiratory Disorders Market Size & Forecast 6.6. Diabetes 6.6.1. Diabetes Market Overview 6.6.2. Diabetes Market Size & Forecast 6.7. Other Therapeutic Areas 6.7.1. Other Therapeutic Areas Market Overview 6.7.2. Other Therapeutic Areas Market Size & Forecast 7. GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE (2017-2024) 7.1. Introduction 7.2. Small Molecules 7.2.1. Small Molecules Market Overview 7.2.2. Small Molecules Market Size & Forecast 7.3. Biologics 7.3.1. Biologics Market Overview 7.3.2. Biologics Market Size & Forecast 8. GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPE (2017-2024) 8.1. Introduction 8.2. Medicinal Chemistry 8.2.1. Medicinal Chemistry Market Overview 8.2.2. Medicinal Chemistry Market Size & Forecast 8.3. Biology Services 8.3.1. Biology Services Market Overview 8.3.2. Biology Services Market Size & Forecast 8.4. Drug Metabolism and Pharmacokinetics (DMPK) 8.4.1. Drug Metabolism and Pharmacokinetics (DMPK) Market Overview 8.4.2. Drug Metabolism and Pharmacokinetics (DMPK) Market Size & Forecast 9. GLOBAL DRUG DISCOVERY SERVICES MARKET, BY GEOGRAPHY (2017-2024) 9.1. North America Drug Discovery Services Market 9.1.1. North America Drug Discovery Services Market, By Type 9.1.2. North America Drug Discovery Services Market, By Drug Type 9.1.3. North America Drug Discovery Services Market, By Therapeutic Area 9.1.4. North America Drug Discovery Services Market, By Process 9.1.5. North America Drug Discovery Services Market, by Region 9.1.5.1. U.S. Drug Discovery Services Market 9.1.5.2. Canada Drug Discovery Services Market 9.1.5.3. Mexico Drug Discovery Services Market 9.2. Europe Drug Discovery Services Market 9.2.1. Europe Drug Discovery Services Market, By Type 9.2.2. Europe Drug Discovery Services Market, By Drug Type 9.2.3. Europe Drug Discovery Services Market, By Therapeutic Area 9.2.4. Europe Drug Discovery Services Market, By Process 9.2.5. Europe Global Drug Discovery Services Market, by Region 9.2.5.1. France Drug Discovery Services Market 9.2.5.2. Germany Drug Discovery Services Market 9.2.5.3. U.K. Drug Discovery Services Market 9.2.5.4. Italy Drug Discovery Services Market 9.2.5.5. Spain Drug Discovery Services Market 9.2.5.6. Rest of Europe Drug Discovery Services Market 9.3. Asia Pacific Drug Discovery Services Market 9.3.1. Asia-Pacific Drug Discovery Services Market, By Type 9.3.2. Asia-Pacific Drug Discovery Services Market, By Drug Type 9.3.3. Asia-Pacific Drug Discovery Services Market, By Therapeutic Area 9.3.4. Asia-Pacific Drug Discovery Services Market, By Process 9.3.5. Asia-Pacific Drug Discovery Services Market, by Region 9.3.5.1. China Drug Discovery Services Market 9.3.5.2. Japan Drug Discovery Services Market 9.3.5.3. India Drug Discovery Services Market 9.3.5.4. South Korea Drug Discovery Services Market 9.3.5.5. Rest of Asia Pacific Drug Discovery Services Market 9.4. Middle East & Africa Drug Discovery Services Market 9.4.1. Middle East & Africa Drug Discovery Services Market, By Type 9.4.2. Middle East & Africa Drug Discovery Services Market, By Drug Type 9.4.3. Middle East & Africa Drug Discovery Services Market, By Therapeutic Area 9.4.4. Middle East & Africa Drug Discovery Services Market, By Process 9.4.5. Middle East & Africa Drug Discovery Services Market, by Region 9.4.5.1. South Africa Drug Discovery Services Market 9.4.5.2. Rest of Middle East and Africa Drug Discovery Services Market 9.5. Latin America Drug Discovery Services Market 9.5.1. Latin America Drug Discovery Services Market, By Type 9.5.2. Latin America Drug Discovery Services Market, By Drug Type 9.5.3. Latin America Drug Discovery Services Market, By Therapeutic Area 9.5.4. North America Drug Discovery Services Market, By Process 9.5.5. Latin America Drug Discovery Services Market, by Region 9.5.5.1. Brazil Drug Discovery Services Market 9.5.5.2. Rest of Latin America Drug Discovery Services Market 10. MARKET COMPETITION ANALYSIS 10.1 Market Share/Positioning Analysis 10.2 Key Innovators 10.3 Company Profiles 10.3.1 GE Healthcare 10.3.1.1 Overview 10.3.1.2 Products/ End-User 10.3.1.3 Strategy 10.3.1.4 Key Developments 10.3.2 Albany Molecular Research, Inc. (AMRI) 10.3.2.1 Overview 10.3.2.2 Products/ End-User 10.3.2.3 Strategy 10.3.2.4 Key Developments 10.3.3 Pharmaceutical Product Development, LLC. (Ppd) 10.3.3.1 Overview 10.3.3.2 Products/ End-User 10.3.3.3 Strategy 10.3.3.4 Key Developments 10.3.4 Syngene 10.3.4.1 Overview 10.3.4.2 Products/ End-User 10.3.4.3 Strategy 10.3.4.4 Key Developments 10.3.5 Wuxi Apptec 10.3.5.1 Overview 10.3.5.2 Products/ End-User 10.3.5.3 Strategy 10.3.5.4 Key Developments 10.3.6 Galapagos NV 10.3.6.1 Overview 10.3.6.2 Products/ End-User 10.3.6.3 Strategy 10.3.6.4 Key Developments 10.3.7 Aurigene Discovery Technologies 10.3.7.1 Overview 10.3.7.2 Products/ End-User 10.3.7.3 Strategy 10.3.7.4 Key Development 10.3.8 Genscript Biotech Corporation 10.3.8.1 Overview 10.3.8.2 Products/ End-User 10.3.8.3 Strategy 10.3.8.4 Key Development 10.3.9 WIL Research Laboratories LLC 10.3.9.1 Overview 10.3.9.2 Products/ End-User 10.3.9.3 Strategy 10.3.9.4 Key Development 10.3.10 Covance 10.3.10.1 Overview 10.3.10.2 Products/ End-User 10.3.10.3 Strategy 10.3.10.4 Key Development 10.3.11 Jubilant Biosys 10.3.11.1 Overview 10.3.11.2 Products/ End-User 10.3.11.3 Strategy 10.3.11.4 Key Development 10.3.12 Evotec 10.3.12.1 Overview 10.3.12.2 Products/ End-User 10.3.12.3 Strategy 10.3.12.4 Key Development 10.3.13 Charles River Laboratories International 10.3.13.1 Overview 10.3.13.2 Products/ End-User 10.3.13.3 Strategy 10.3.13.4 Key Development 10.3.14 Merck 10.3.14.1 Overview 10.3.14.2 Products/ End-User 10.3.14.3 Strategy 10.3.14.4 Key Development 10.3.15 Thermo Fisher Scientific 10.3.15.1 Overview 10.3.15.2 Products/ End-User 10.3.15.3 Strategy 10.3.15.4 Key Development

Inquiry Before Buying

Request Sample

About This Report

Report ID6672
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now